US9663504B2

Salts of heterocyclic modulators of HIF activity for treatment of disease

University of Texas System

Abstract

The present disclosure relates to salts of heterocyclic compounds and methods that inhibit HIF pathway activity. The compounds are designed to treat or prevent cancer and other hypoxia-mediated diseases.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Philip Jones
Priority date: February 25, 2014
Filing date: February 25, 2015
Grant date: May 30, 2017
Publication date: May 30, 2017
Language: en
PDF source: https://patentimages.storage.googleapis.com/98/4b/5b/2b2a1fb47edff9/US9663504.pdf
Metadata fetched: August 29, 2026 00:24